Epigenetic targets in the diagnosis and treatment of prostate cancer



Document title: Epigenetic targets in the diagnosis and treatment of prostate cancer
Journal: International braz j urol
Database: PERIÓDICA
System number: 000296993
ISSN: 1677-5538
Authors: 1



2
Institutions: 1University of Miami, Miller School of Medicine, Miami, Florida. Brasil
2Miami VA Medical Center, Miami, Florida. Brasil
Year:
Season: Ene-Feb
Volumen: 33
Number: 1
Pages: 11-18
Country: Brasil
Language: Inglés
Document type: Artículo
Approach: Teórico, descriptivo
English abstract Prostate cancer (PC) is one of leading cause of cancer related deaths in men. Various aspects of cancer epigenetics are rapidly evolving and the role of 2 major epigenetic changes including DNA methylation and histone modifications in prostate cancer is being studied widely. The epigenetic changes are early event in the cancer development and are reversible. Novel epigenetic markers are being studied, which have the potential as sensitive diagnostic and prognostic marker. Variety of drugs targeting epigenetic changes are being studied, which can be effective individually or in combination with other conventional drugs in PC treatment. In this review, we discuss epigenetic changes associated with PC and their potential diagnostic and therapeutic applications including future areas of research
Disciplines: Medicina
Keyword: Cirugía,
Diagnóstico,
Oncología,
Cáncer,
Próstata,
Epigénesis,
ADN,
Metilación
Keyword: Medicine,
Diagnosis,
Oncology,
Surgery,
Cancer,
Prostate,
Epigenesis,
DNA,
Methylation
Full text: Texto completo (Ver HTML)